CORRECTION

J. Pharm. Pharm. Sci., 17 February 2026

Volume 29 - 2026 | https://doi.org/10.3389/jpps.2026.15563

Corrigendum: Optimized Ginkgo biloba extract EGb 761®: boosted therapeutic benefits with minimized CYP enzyme interference

  • 1. Department of Convergent Biotechnology and Advanced Materials Science, College of Life Sciences, Kyung Hee University, Yongin, Republic of Korea

  • 2. BK21 Interdisciplinary Program in IT-Bio Convergence System, Kyung Hee University, Yongin, Republic of Korea

Article metrics

13

Views

37

Downloads

In the published article, references 27 and 28 were cited in the Conclusion section. Due to the text correction listed below, these citations have been removed.

In the published article, there is an erroneous statement in the Conclusion section: “The potential inhibitory effects of PCA on CYP1A2, CYP2E1, CYP2D6, and CYP3A4 have been reported based on molecular docking simulations [27]. In particular, in vivo animal studies have demonstrated that PCA inhibits the enzymatic activity of CYP1A2 and CYP2E1 [28]. On the basis of prior research, it is reasonable to hypothesize that the enhanced CYP inhibition observed in EGb 761®, A4, and B2 is associated with their high concentrations of PCA.”

The correct statement is “While a direct causal relationship between reduced CYP inhibitory activity and PCA could not be definitively confirmed–due to the presence of numerous other compounds in EGb 761® and other raw materials or final drug products–further research is needed to clarify this relationship, as the chemical composition of G. biloba extracts is well-documented.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Summary

Keywords

EGb 761®, protocatechuic acid, cognitive enhancement, molecular docking, CYP inhibition

Citation

Kwon S, Jeong S and Lee S (2026) Corrigendum: Optimized Ginkgo biloba extract EGb 761®: boosted therapeutic benefits with minimized CYP enzyme interference. J. Pharm. Pharm. Sci. 29:15563. doi: 10.3389/jpps.2026.15563

Received

10 September 2025

Revised

29 October 2025

Accepted

30 January 2026

Published

17 February 2026

Approved by

Journal of Pharmacy & Pharmaceutical Sciences Editorial Office, Frontiers Media SA, Switzerland

Volume

29 - 2026

Updates

Copyright

*Correspondence: Seulah Lee,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Cite article

Copy to clipboard


Export citation file


Share article